首頁 > 市場調查報告書 > 製藥

市場調查報告書

商品編碼

1732186

全球藥房配藥市場規模（按配藥類型、治療領域、應用和地區分類）預測

Global Compounding Pharmacy Market Size By Compounding Type, By Therapeutic Area (Pain Management, Hormone Replacement Therapy ), By Application, By Geographic Scope And Forecast

出版日期: 2025年04月29日 | 出版商:

Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

配藥藥房的市場規模與預測

2024 年全球複合藥局市場規模為 115.5 億美元，預計到 2032 年將達到 180 億美元，2026 年至 2032 年的複合年成長率為 5.70%。

調配藥局是專門的機構，藥師可依每位患者的需求，調配訂製藥物。與大量生產的藥物不同，調配藥物是透過組合或改變成分來提供特定劑量、配方或給藥方式，而這些劑量、配方或給藥方式可能在市場上無法取得。對於需要不含特定過敏原、不同藥效或需要替代劑型（例如液體或錠劑）的患者來說，這種做法至關重要。

複合藥房廣泛應用於皮膚科、荷爾蒙補充療法、小兒科和獸醫學等細分醫學專科。其個人化治療能力使其成為解決患者獨特醫療挑戰的關鍵。由於人口老化、慢性病發病率上升以及個人化醫療的興起，複合藥物的需求預計將持續成長。隨著自動化和品管改進等技術進步，複合藥局將在醫療保健領域發揮更大作用，並提供創新解決方案，從而改善患者的治療效果。

全球藥局市場動態

影響全球醫藥市場的關鍵市場動態是：

關鍵市場促進因素

慢性病發病率上升和個人化醫療趨勢日益成長，推動了對複合藥物的需求。根據美國疾病管制與預防中心 ( 美國美國至少患有一種慢性疾病，27.2% 的成年人患有多種慢性疾病。慢性病的高發生率催生了對複合藥房能夠提供的定製藥物的需求。

人口老化加劇：人口老化是複方藥局市場的主要驅動力，因為老年人通常需要專門的藥物。美國人口普查局預測，到2030年，所有嬰兒潮世代都將達到65歲或以上，這將增加老年人口的規模，五分之一的居民將達到退休年齡。這種人口結構變化將增加針對老年人需求的複合藥物的需求。

FDA認證核可藥短缺：藥品短缺一直是醫療保健行業的長期問題，這為配藥藥房填補這一缺口創造了機會。根據 FDA 藥品短缺資料庫，截至 2021 年，共有 115 種藥品短缺。美國衛生系統藥劑師協會 (ASHP) 報告稱，截至 2021 年 12 月 31 日，共有 211 種藥品短缺。這些藥品短缺通常會導致醫療保健提供者轉向配藥藥房尋求替代方案。

主要挑戰

法規遵循：遵守各種地方、州和聯邦法規是最大的挑戰之一。藥局必須符合FDA和USP等機構制定的標準，這可能需要昂貴的設施升級和持續的培訓。不遵守規定可能會導致處罰、聲譽受損，甚至倒閉，影響整個業務。

品管：由於成分和配方的差異，確保所配的藥物品質一致並非易事。品管不力可能導致患者出現不良反應，甚至導致藥物無效。藥房必須投資於完善的系統和測試，這不僅會增加出錯的風險，還會增加營運成本。

供應鏈中斷：藥局依賴全球採購的原料。地緣政治問題、運輸延誤和供不應求等因素都可能擾亂業務。醫藥級原料供應有限，可能需要昂貴的替代品，進而影響定價和客戶維繫。

主要趨勢

定製藥物：個人化醫療是一種日益成長的趨勢，即根據患者的個人需求定製藥物，包括劑型、強度、成分等。隨著患者尋求針對大規模生產的藥物無法解決的獨特醫療狀況的更精準治療，這種趨勢將推動成長，從而增加對藥房服務的需求。

生物同質性荷爾蒙需求日益成長：生物同質性荷爾蒙補充療法(BHRT) 正日益流行，尤其是在尋求自然療法解決荷爾蒙失衡問題的老年人群體中。能夠客製化 BHRT 配方的複方藥房可以充分利用這個不斷成長的市場，提供傳統藥物無法提供的個人化選擇。

更重視兒科和老年護理：兒科和老年患者通常需要具有特定給藥方案的客製化藥物，例如液體、咀嚼片等。配藥藥房在製作這些定製配方中發揮著關鍵作用，隨著醫療保健提供者越來越關注針對這些弱勢年齡群體的個人化治療，配藥藥房的需求不斷成長。

A compounding pharmacy is a specialized facility where pharmacists create customized medications tailored to individual patient needs. Unlike mass-produced pharmaceuticals, compounded medications are prepared by combining or altering ingredients to provide specific dosages, formulations, or delivery methods that may not be commercially available. This practice is essential for patients who require medications free from certain allergens, different dosage strengths, or alternative forms such as liquids or creams instead of pills.

Compounding pharmacies are widely used in niche medical fields like dermatology, hormone replacement therapy, pediatrics, and veterinary medicine, where standard medications may not suffice. Their ability to personalize treatments has made them crucial in addressing patient-specific medical challenges. The demand for compounded medications is expected to grow due to an aging population, increasing chronic diseases, and the rise of personalized medicine. With advancements in technology, such as automation and improved quality control, compounding pharmacies are likely to play a greater role in healthcare, offering innovative solutions that enhance patient outcomes.

Global Compounding Pharmacy Market Dynamics

The key market dynamics that are shaping the global compounding pharmacy market include:

Key Market Drivers:

Increasing Prevalence of Chronic Diseases and Personalized Medicine: The rise in chronic diseases and the growing trend towards personalized medicine are driving the demand for compounded medications. According to the Centers for Disease Control and Prevention (CDC), as of 2018, 51.8% of U.S. adults had at least one chronic condition, and 27.2% had multiple chronic conditions. This high prevalence of chronic diseases creates a need for tailored medications that compounding pharmacies can provide.

Growing Aging Population: The aging population is a significant driver for the compounding pharmacy market, as older adults often require specialized medications. The U.S. Census Bureau projects that by 2030, all baby boomers will be older than 65, expanding the size of the older population so that 1 in every 5 residents will be of retirement age. This demographic shift is likely to increase the demand for compounded medications tailored to the needs of older adults.

Shortages of FDA-Approved Drugs: Drug shortages have become a persistent problem in the healthcare industry, creating opportunities for compounding pharmacies to fill the gap. According to the FDA's drug shortages database, as of 2021, there were 115 drugs in shortage. The American Society of Health-System Pharmacists (ASHP) reported even higher numbers, with 211 active drug shortages as of December 31, 2021. These shortages often lead healthcare providers to turn to compounding pharmacies for alternatives.

Key Challenges:

Regulatory Compliance: Compliance with varying local, state, and federal regulations is one of the biggest challenges. Pharmacies must meet standards set by organizations like the FDA and USP. This can involve costly facility upgrades and continuous training. Failure to comply can result in penalties, reputational damage, or even closure, affecting the overall operation.

Quality Control: Ensuring consistent quality in compounded medications is difficult due to variability in ingredients and formulations. Poor quality control can lead to adverse effects or inefficacy in patients. Pharmacies must invest in robust systems and testing, adding operational costs while increasing the risk of errors.

Supply Chain Disruptions: Compounding pharmacies rely on raw materials sourced globally. Any disruptions, such as geopolitical issues, transportation delays, or supply shortages, can hinder operations. Limited availability of pharmaceutical-grade ingredients may result in costly alternatives, affecting pricing and customer retention.

Key Trends:

Customization of Medications: Personalized medicine is a growing trend, where medications are tailored to individual patient's needs, including dosage forms, strengths, and ingredients. This trend drives growth as patients seek more precise treatments for unique medical conditions that cannot be met by mass-produced pharmaceuticals, increasing demand for compounding services.

Rising Demand for Bioidentical Hormones: Bioidentical hormone replacement therapy (BHRT) is gaining popularity, particularly among aging populations seeking natural solutions for hormone imbalances. Compounding pharmacies can create customized BHRT formulations, tapping into this expanding market and offering tailored options that aren't available through conventional pharmaceuticals.

Increased Focus on Pediatric and Geriatric Care: Both pediatric and geriatric patients often require tailored medications in specific dosages or formats, such as liquid forms or chewable tablets. Compounding pharmacies play a crucial role in creating these custom formulations, driving demand as healthcare providers increasingly turn to personalized treatments for these vulnerable age groups.

Global Compounding Pharmacy Market Regional Analysis

Here is a more detailed regional analysis of the global compounding pharmacy market:

North America:

North America, especially the United States, is leading the compounding pharmacy market due to several key factors. One major driver is the rising prevalence of chronic diseases, with the Centers for Disease Control and Prevention (CDC) noting that 60% of adults in the U.S. have at least one chronic condition, and 40% have multiple conditions. This trend creates a substantial demand for personalized medications, which compounding pharmacies can uniquely provide. As the CDC projects that by 2030, 171 million Americans will have multiple chronic conditions, the need for specialized pharmaceutical services is expected to grow significantly.

The aging population in North America is a critical factor fueling demand for compounded medications. The U.S. Census Bureau anticipates that by 2030, one in five residents will be over the age of 65, which will naturally increase healthcare expenditures. The Centers for Medicare & Medicaid Services (CMS) reported a 9.7% growth in healthcare spending in 2020, reaching $4.1 trillion, with projections of $6.2 trillion by 2028.

Persistent drug shortages reported by the FDA are prompting healthcare providers to turn to compounding pharmacies for alternatives. The regulatory environment, particularly through the Drug Quality and Security Act (DQSA) of 2013, has also bolstered market growth by enhancing the legitimacy and safety standards of compounding pharmacies. Combined with a growing trend toward personalized medicine-where 25% of new drugs approved in 2021 were tailored therapies-the landscape is ripe for continued growth in the North American compounding pharmacy market.

Asia Pacific:

The Asia Pacific region is witnessing significant growth in the compounding pharmacy market, primarily driven by the rising burden of chronic diseases. The World Health Organization (WHO) highlights those non-communicable diseases (NCDs) account for 71% of global deaths, with low- and middle-income countries in this region being disproportionately affected. By 2030, the WHO projects that deaths from NCDs in Southeast Asia will rise to 10.4 million annually, up from 8.5 million in 2012. This escalating health crisis creates a substantial demand for personalized medications, which compounding pharmacies are uniquely positioned to supply. The rapidly aging population, expected to more than double from 630 million in 2020 to approximately 1.3 billion by 2050, adds to this demand, especially in countries like Japan, where nearly 38% of the population will be over 65 by 2050.

In addition to health trends, increasing healthcare expenditures in the region are bolstering the compounding pharmacy market. With healthcare spending in East Asia and the Pacific rising from 6.45% of GDP in 2010 to 7.13% in 2019, investment in specialized pharmaceutical services is expected to grow significantly. The Asia Pacific pharmaceutical market is anticipated to reach $385 billion by 2026, creating ample opportunities for compounding pharmacies. The regulatory landscape is also evolving, with countries like Australia implementing new regulations to ensure quality and safety in compounded medications. Drug shortages further enhance the market potential, as healthcare providers increasingly seek alternatives from compounding pharmacies amid significant medicine shortages reported by regulatory bodies.

Global Compounding Pharmacy Market: Segmentation Analysis

The Global is Segmented on the basis of Compounding Type, Therapeutic Area, Application, And Geography.

Compounding Pharmacy Market, By Compounding Type

Sterile Compounding
Non-Sterile Compounding

Based on Compounding Type, the market is fragmented into Sterile Compounding and Non-Sterile Compounding. Sterile compounding is dominating the market due to the increasing demand for customized injectable medications, intravenous (IV) therapies, and other sterile formulations required for patients with specific health conditions, such as cancer or chronic diseases. Strict regulatory standards and the need for quality assurance further enhance the prominence of sterile compounding in the healthcare landscape. Non-sterile compounding is rapidly growing as healthcare providers and patients seek personalized oral medications, topical creams, and other formulations tailored to individual needs, particularly in pediatrics and dermatology. The increasing focus on patient-centered care and the rise in chronic conditions that require individualized treatment plans are propelling the demand for both sterile and non-sterile compounding.

Compounding Pharmacy, By Therapeutic Area
Pain Management,
Hormone Replacement Therapy (HRT

Based on Therapeutic Area, the market is divided into Pain Management and Hormone Replacement Therapy (HRT). The compounding pharmacy market is prominently driven by the therapeutic areas of pain management and hormone replacement therapy (HRT), both of which are experiencing significant growth. Pain management is a critical area as the increasing prevalence of chronic pain conditions, such as arthritis and neuropathy, has led to a heightened demand for personalized pain relief options that compounded medications can provide, especially for patients who may not respond well to standard treatments. Hormone replacement therapy is rapidly expanding, particularly among aging populations seeking to manage symptoms of menopause and andropause. Compounding pharmacies can tailor hormone formulations to meet individual patient needs, ensuring optimal efficacy and minimizing side effects. The growing awareness and acceptance of personalized treatment options in both pain management and HRT are driving substantial growth in these segments of the compounding pharmacy market.

Compounding Pharmacy Market, By Application

Veterinary Medicine
Pediatrics

Based on Application, the market is segmented into Veterinary Medicine and Pediatrics. The compounding pharmacy market is significantly influenced by the applications in veterinary medicine and pediatrics, with both segments experiencing growing demand. In veterinary medicine, compounded medications are essential for customizing treatments for pets with unique health needs, such as specific dosages or formulations that are not commercially available. The pediatrics segment is expanding as children often require specialized dosages and formulations, such as liquids or flavored medications, to ensure proper administration and compliance. As awareness of the benefits of personalized medicine increases among healthcare providers and pet owners, the demand for compounded medications in these applications is expected to rise.

Compounding Pharmacy Market, By Geography

North America
Asia Pacific
Europe
Rest of the world
On the basis of geographical analysis, the Global Compounding Pharmacy Market is classified into North America, Asia Pacific, Europe, and Rest of the world. The global compounding pharmacy market is notably dominated by North America and is rapidly growing in the Asia Pacific region. North America leads due to a high prevalence of chronic diseases, an aging population, and increasing healthcare expenditures, driving demand for personalized medications. The Asia Pacific region is experiencing rapid expansion fueled by the rising burden of chronic diseases, a rapidly aging demographic, and increasing healthcare spending. The region's pharmaceutical market is projected to grow significantly.

Key Players

The "Global Compounding Pharmacy Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Fagron, B. Braun Melsungen AG, Nephron Pharmaceuticals Corporation, Fresenius Kabi, PharMEDium Services, QuVa Pharma, Triangle Compounding Pharmacies, Pencol ii Pharmacy, Smith Drug Company, and Rx3 Compounding Pharmacy. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Compounding Pharmacy Market Recent developments
In April 2024, Myonex, a global clinical trial supply company, announced that it hadcompleted its acquisition of Saveway Compounding Pharmacy. The acquisition allow Myonex to better supply patients in clinical trials with medication and equipment as needed. It will also help the company expand its clinical trial designs and include direct-to-patient and home healthcare provider capabilities.
In November 2023, Precision Compounding Pharmacy, a technology-enabled compounding pharmacy that fulfills telemedicine prescriptions, announced that it had received a seed investment from Right Side Capital Management, a technology investment firm. The funds will allow Precision Compounding Pharmacy to enhance its suite of services, broaden its reach, and drive innovation in the pharmacy industry.

1 INTRODUCTION OF GLOBAL COMPOUNDING PHARMACIES MARKET

1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL COMPOUNDING PHARMACIES MARKET OUTLOOK

4.1 Overview
4.2 Market Dynamics
- 4.2.1 Drivers
- 4.2.2 Restraints
- 4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis

5 GLOBAL COMPOUNDING PHARMACIES MARKET, BY COMPOUNDING TYPE

5.1 Overview
5.2 Sterile Compounding
5.3 Non-Sterile Compounding

6 GLOBAL COMPOUNDING PHARMACIES MARKET, BY THERAPEUTIC AREA

6.1 Overview
6.2 Pain Management
6.3 Hormone Replacement Therapy (HRT)

7 GLOBAL COMPOUNDING PHARMACIES MARKET, BY APPLICATION

7.1 Overview
7.2 Veterinary Medicine
7.3 Pediatrics

8 GLOBAL COMPOUNDING PHARMACIES MARKET, BY GEOGRAPHY

8.1 Overview
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
- 8.2.3 Mexico
8.3 Europe
- 8.3.1 Germany
- 8.3.2 U.K.
- 8.3.3 France
- 8.3.4 Rest of Europe
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Rest of Asia Pacific
8.5 Rest of the World
- 8.5.1 Latin America
- 8.5.2 Middle East & Africa

9 GLOBAL COMPOUNDING PHARMACIES MARKET COMPETITIVE LANDSCAPE

9.1 Overview
9.2 Company Market Ranking
9.3 Key Development Strategies

10 COMPANY PROFILES

10.1 Braun Melsungen AG Company
- 10.1.1 Overview
- 10.1.2 Financial Performance
- 10.1.3 Product Outlook
- 10.1.4 Key Developments
10.2 Cantrell Drug Company
- 10.2.1 Overview
- 10.2.2 Financial Performance
- 10.2.3 Product Outlook
- 10.2.4 Key Developments
10.3 Fagron
- 10.3.1 Overview
- 10.3.2 Financial Performance
- 10.3.3 Product Outlook
- 10.3.4 Key Developments
10.4 Fresenius Kabi AG
- 10.4.1 Overview
- 10.4.2 Financial Performance
- 10.4.3 Product Outlook
- 10.4.4 Key Developments
10.5 Institutional Pharmacy Solutions
- 10.5.1 Overview
- 10.5.2 Financial Performance
- 10.5.3 Product Outlook
- 10.5.4 Key Developments
10.6 Lorraine's Pharmacy
- 10.6.1 Overview
- 10.6.2 Financial Performance
- 10.6.3 Product Outlook
- 10.6.4 Key Developments
10.7 PharMEDium Services LLC
- 10.7.1 Overview
- 10.7.2 Financial Performance
- 10.7.3 Product Outlook
- 10.7.4 Key Developments
10.8 Triangle Compounding Pharmacies
- 10.8.1 Overview
- 10.8.2 Financial Performance
- 10.8.3 Product Outlook
- 10.8.4 Key Developments